https://www.marketscreener.com/quote/stock/CANTARGIA-AB-31837413/news/Cantargia-AB-Reports-Progress-Towards-Start-of-DOT-Sponsored-Clinical-Trial-of-Nadunolimab-in-Leukem-46297289/?utm_source=telegram&utm_medium=social&utm_campaign=share